Hypothesis: the working mechanims of metformin can be partly explained by its effect on the composition of the gut microbiota, with changes in inretin secretion and inflammatory pathways as secondary effects.
ID
Bron
Verkorte titel
Aandoening
Type 2 diabetes, metformin, gutmicrobiota
Ondersteuning
PO Box 22660
1100 DD Amsterdam
Netherlands
PO Box 22660
1100 DD Amsterdam
Netherlands
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Changes in faecal flora after 15 weeks.
Achtergrond van het onderzoek
Metformin is the first line treatment in newly diagnosed patients with diabetes type 2. Metformin is an effective anti-hyperglycemic agent, although its precise mechanism of action is still unknown. In our study we will try to confirm the hypothesis that the working mechanism of metformin can be partly explained by its effect on the gut microbiota by studying both bacterial changes and these pathways simultaneously. Thus, the improved insulin sensitivity with metformin use can probably be explained by the influence of metformin on the composition of the gut microbiota, with changes in incretin secretion and inflammation pathways as secondary effectors.
Doel van het onderzoek
Hypothesis: the working mechanims of metformin can be partly explained by its effect on the composition of the gut microbiota, with changes in inretin secretion and inflammatory pathways as secondary effects.
Onderzoeksopzet
1. Baseline;
2. 5wk;
3. 10wk;
4. 15wk.
Onderzoeksproduct en/of interventie
1. Arm 1- 15 weeks metformin;
2. Arm 2- 15 weeks insulin (lantus).
Publiek
A. Vrieze
Academic Medical Center, room F4-256
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5665983
a.vrieze@amc.uva.nl
Wetenschappelijk
A. Vrieze
Academic Medical Center, room F4-256
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5665983
a.vrieze@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Male obese subjects with an impaired fasting glucose or newly diagnosed diabetes;
2. 21-65 yr;
3. BMI <45 kg/m2.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Renal failure;
2. Liver function problems;
3. (History of) alcoholism.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL1674 |
| NTR-old | NTR1775 |
| Ander register | CCMO : 26948 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |